Safety of Effivia®, a Bevacizumab Biosimilar

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

NCT05249426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT00906360 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer

NCT03071848 ·Status: COMPLETED

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

NCT00025233 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

NCT01309633 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00409565 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

NCT00600210 ·Status: WITHDRAWN ·Phase: PHASE2

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

NCT00626561 ·Status: TERMINATED ·Phase: PHASE2

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

NCT00968435 ·Status: COMPLETED ·Phase: PHASE2

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

NCT05063552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

BIBW 2992 (Afatinib) in Head & Neck Cancer

NCT00514943 ·Status: COMPLETED ·Phase: PHASE2

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT01816984 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

NCT02921269 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

NCT05179317 ·Status: UNKNOWN ·Phase: PHASE2

Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.

NCT06670911 ·Status: RECRUITING ·Phase: PHASE2

Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

NCT01012297 ·Status: TERMINATED ·Phase: PHASE3

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

NCT00369122 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

NCT00803062 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)

NCT02674009 ·Status: COMPLETED

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT07063212 ·Status: RECRUITING ·Phase: PHASE2

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

NCT06543576 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Gefitinib in Treating Patients With Cervical Cancer

NCT00049556 ·Status: COMPLETED ·Phase: PHASE2

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

NCT05998941 ·Status: WITHDRAWN ·Phase: PHASE2